A Phase 4, Double-blind, Sequential Cohort Study of Pain Treatment and Recovery After Total Knee Arthroplasty
Latest Information Update: 21 May 2026
At a glance
- Drugs Suzetrigine (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Vertex Pharmaceuticals
Most Recent Events
- 13 May 2026 Status changed from not yet recruiting to recruiting.
- 27 Apr 2026 New trial record